August 11-18, 2016
Last Updated: Aug 12, 2016
- ESR1 Mutations in Cell-Free DNA of Breast Cancer Predictive “Tip of the Iceberg"
Suzanne A. W. Fuqua et al, JAMA Oncology, August 11, 2016 - Prevalence of ESR1 Mutations in Cell-Free DNA and Outcomes in Metastatic Breast Cancer A Secondary Analysis of the BOLERO-2 Clinical Trial
Sarat Chandarlapaty, et al, JAMA Oncology, August 11, 2016 - Factors Associated with Interest in Gene-Panel Testing and Risk Communication Preferences in Women from BRCA1/2 Negative Families.
Flores Kristina G et al. Journal of genetic counseling 2016 Aug - LRG1 mRNA expression in breast cancer associates with PIK3CA genotype and with aromatase inhibitor therapy outcome.
Ramirez-Ardila Diana E, et al. Molecular oncology 2016 7 - A pooled analysis of CYP2D6 genotype in breast cancer prevention trials of low-dose tamoxifen.
Johansson Harriet, et al. Breast cancer research and treatment 2016 8 - Genetic variations in the Hippo signaling pathway and breast cancer risk in African American women in the AMBER Consortium.
Zhang Jianmin, et al. Carcinogenesis 2016 8 - The breast cancer susceptibility-related polymorphisms at the TOX3/LOC643714 locus associated with lung cancer risk in a Han Chinese population.
Jiang Chaowen, et al. Oncotarget 2016 7 - Low-frequency nonsynonymous variants in FKBPL and ARPC1B genes are associated with breast cancer risk in Chinese women.
Zhou Wen, et al. Molecular carcinogenesis 2016 8 - PADI2 gene confers susceptibility to breast cancer and plays tumorigenic role via ACSL4, BINC3 and CA9 signaling.
Wang Huifeng, et al. Cancer cell international 2016 0 61 - Genetic testing and personalized ovarian cancer screening: a survey of public attitudes.
Meisel Susanne F et al. BMC women's health 2016 16(1) 46 - Internet-based physical activity intervention for women with a family history of breast cancer.
Hartman Sheri J et al. Health psychology : official journal of the Division of Health Psychology, American Psychological Association 2015 Dec 34 Suppl1296-304 - Iranian women's attitude toward prophylactic mastectomy for breast cancer.
Majidzadeh-A Keivan et al. Journal of cancer research and therapeutics 12(2) 915-9 - Stratified, precision or personalised medicine? Cancer services in the 'real world' of a London hospital.
Day Sophie et al. Sociology of health & illness 2016 Jul - Updated guidelines for breast cancer increase number of patients who test HER2-positive,
News-Medical.net, July 28, 2016 - A Survey of BRCA1, BRCA2, and PALB2 mutations in women with breast cancer in Trinidad and Tobago.
Donenberg Talia, et al. Breast cancer research and treatment 2016 7
- Human (5264)
- Pathogen (0)
- Human (453)
- Pathogen (0)
- Huamn (122)
- Pathogen (0)
.png)
No hay comentarios:
Publicar un comentario